AquaBounty Technologies Inc
NASDAQ:AQB
AquaBounty Technologies Inc
AquaBounty Technologies, Inc. engages in the provision of land-based aquaculture services. The company is headquartered in Maynard, Massachusetts and currently employs 76 full-time employees. The company went IPO on 2017-01-09. The firm's GE Atlantic salmon is based upon salmon genetics and grows to harvest size faster than conventional Atlantic salmon. The company farms its GE Atlantic salmon in land-based, recirculating aquaculture systems (RAS). The closed, contained, land-based production systems using RAS technology that the Company uses for the grow-out of its fish are less susceptible to the disease-related pressures of conventional salmon farming. Its RAS facilities provide water treatment technology, including the use of ozone, salt treatment and ultraviolet radiation to kill potential bacterial, fungal, or viral pathogens, which might enter the system. Its GE Atlantic salmon is based upon a single, specific molecular modification in the fish that results in rapid growth in early development. The company has two salmon farms in production, one is located in Indiana and the other located in Prince Edward Island, Canada.
AquaBounty Technologies, Inc. engages in the provision of land-based aquaculture services. The company is headquartered in Maynard, Massachusetts and currently employs 76 full-time employees. The company went IPO on 2017-01-09. The firm's GE Atlantic salmon is based upon salmon genetics and grows to harvest size faster than conventional Atlantic salmon. The company farms its GE Atlantic salmon in land-based, recirculating aquaculture systems (RAS). The closed, contained, land-based production systems using RAS technology that the Company uses for the grow-out of its fish are less susceptible to the disease-related pressures of conventional salmon farming. Its RAS facilities provide water treatment technology, including the use of ozone, salt treatment and ultraviolet radiation to kill potential bacterial, fungal, or viral pathogens, which might enter the system. Its GE Atlantic salmon is based upon a single, specific molecular modification in the fish that results in rapid growth in early development. The company has two salmon farms in production, one is located in Indiana and the other located in Prince Edward Island, Canada.
